Skip to content
Business
Prognosis

Two Chinese mRNA Covid Vaccines Move Toward Clinical Trials

  • CSPC Pharma’s vaccine approved for clinical trial in China
  • China’s regulator has not yet approved any mRNA vaccines
Video player cover image
WATCH: Shanghai reported 9,006 daily Covid cases for Sunday as the city begins a new round of mass tests on Monday. Source: Bloomberg

Sign up here for our daily coronavirus newsletter on what you need to know

A Chinese company said it’s received approval to start clinical trials of a Covid-19 vaccine based on mRNA technology, while local media reported that another domestic company has applied to start a similar trial.